Action Antibe Therapeutics - ATE

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,295

Prix Achat

0,09

Prix Vente

0,09

Volume échangé

0,00 Fourchette du Jour 0,00

0,295 Plage de 52 semaines 0,295

Clôture Veille

0,295

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Antibe Announces Appointment of Receiver

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced...

Antibe Provides Update on CCAA Proceedings

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay...

Antibe Announces TSX Delisting Review

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”) is reviewing the eligibility...

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial...

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the...

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of...

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

- The American Society of Regional Anesthesia and Pain Medicine is the largest subspecialty medical society in anesthesiology Antibe Therapeutics...

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

- AAPM is the primary organization for pain medicine physicians in the U.S. Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage...

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain...

Antibe Reports Q3 2024 Interim Financial and Operating Results

- Successful PK/PD study confirms liver safety, sets stage for upgraded Phase II trial launch next month - Phase II trial enhancements include...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.295	0.295	0.295	0	0	CS
4	0	0	0.295	0.295	0.295	0	0	CS
12	0	0	0.295	0.295	0.295	0	0	CS
26	0	0	0.295	0.295	0.295	0	0	CS
52	0	0	0.295	0.295	0.295	0	0	CS
156	-0.455	-60.6666666667	0.75	1.23	0.15	31615	0.59114102	CS
260	-0.12	-28.9156626506	0.415	7.52	0.15	83316	1.86199007	CS

ATE - Frequently Asked Questions (FAQ)

What is the current Antibe Therapeutics share price?

The current share price of Antibe Therapeutics is $ 0,295

What is the 1 year trading range for Antibe Therapeutics share price?

Antibe Therapeutics has traded in the range of $ 0,295 to $ 0,295 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
PNC.BPostmedia Network Canada Corp	$ 1,10 (37,50%)	11,2k
PNC.APostmedia Network Canada Corp	$ 1,07 (25,88%)	3,4k
FLNTFlint Corporation	$ 0,025 (25,00%)	245,17k
APLIAppili Therapeutics Inc	$ 0,03 (20,00%)	185k
SLT.USaltire Capital Ltd	US$ 8,36 (19,43%)	1,1k
VRTSVertiqal Studios Corporation	$ 0,015 (-25,00%)	60k
GMTNGold Mountain Mining Corp	$ 0,015 (-25,00%)	1,07k
THNCThinkific Labs Inc	$ 2,30 (-19,30%)	19,12k
PPRPrairie Provident Resources Inc	$ 0,03 (-14,29%)	82k
LNLoncor Gold Inc	$ 0,60 (-14,29%)	336,22k
CNQCanadian Natural Resources Ltd	$ 39,89 (2,10%)	19,86M
TDToronto Dominion Bank	$ 83,99 (0,23%)	12,16M
CVECenovus Energy Inc	$ 16,75 (3,65%)	8,12M
ENBEnbridge Inc	$ 62,81 (1,45%)	5,23M
WCPWhitecap Resources Inc	$ 8,20 (2,50%)	4,68M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Antibe Therapeutics Inc (ATE)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés